HKEX Filings
-
Apr 2, 2026
Inside Information - Supplemental Announcement in Relation to Inside Information
-
Mar 30, 2026Voluntary Announcement Clover Completes Enrollment in Australian Phase 2 Clinical Trial for RSV + hMPV + PIV3 Respiratory Combination Vaccine Candidates
-
Mar 27, 2026Grant of Options Pursuant to the Post-IPO Share Option Plan and Grant oOf RSUs Pursuant to the RSU Scheme
-
Mar 26, 2026Annual Results Announcement for The Year Ended December 31, 2025 and Proposed Amendments to the Memorandum and Articles of Association
-
Mar 25, 2026Voluntary Announcement Clover Announces Additional Positive US Phase I Clinical Data for RSV Re-Vaccination in Older Adults
-
Mar 22, 2026Inside Information - Settlement Announcement with GAVI
-
Mar 13, 2026Date of Board Meeting
-
Mar 5, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2026
-
Feb 4, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2026
-
Jan 12, 2026Voluntary Announcement Clover Initiates Phase 2 Clinical Trial for RSV-hMPV-PIV3 Respiratory Combination Vaccine Candidates
-
Jan 7, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2025
-
Dec 4, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2025
-
Nov 5, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2025
-
Oct 14, 2025Voluntary announcement Clover announces positive phase I clinical data for RSV-HMPV-PIV3 combination vaccines and for RSV re-vaccination in older adults
-
Oct 3, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2025
-
Sep 18, 20252025 Interim Report
-
Sep 4, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended August 31, 2025
-
Aug 27, 2025Interim Results Announcement for the Six Months Ended June 30, 2025
-
Aug 14, 2025Date of Board Meeting
-
Aug 5, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended July 31, 2025
